SUBSCRIBE
SUBSCRIBE

AMPEL BioSolutions

IN THE PRESS
BioCapital
AMPEL BioSolutions’ Lupus Test Launches to Predict Flares & Drug Targets
March 27, 2024
 · 
13 min read
BioCapital
AMPEL BioSolutions’ Breakthrough Predicts Drug Options to Slow End Stage Renal Disease
March 1, 2023
 · 
8 min read
BioCapital
AMPEL BioSolutions’ Breakthrough Predicts Drug Options for Fibromyalgia
January 31, 2023
 · 
6 min read
Business
Virginia Based AMPEL BioSolutions’ Machine Learning Breakthrough Predicts Drug Options for Inflammatory Skin Diseases
May 3, 2022
 · 
4 min read
BioCapital
AMPEL BioSolutions to Present at 2021 BioHealth Capital Region Forum
September 14, 2021
 · 
3 min read
BioCapital
Virginia Based AMPEL BioSolutions’ Technology Predicts Severity of Illness in COVID19 Patients and Identifies Treatments
June 9, 2020
 · 
2 min read
Biotech Bay
AMPEL BioSolutions Announces Gene-Based Lupus Diagnostic At Biotech Showcase In San Francisco
January 17, 2020
 · 
3 min read
BioCapital
Virginia Based AMPEL BioSolutions’ Machine Learning Breakthrough Predicts Chronic Disease Flares From A Blood Sample
July 9, 2019
 · 
7 min read
BioCapital
AMPEL BioSolutions and MedNet Solutions Partner to Host Virginia Biotechnology Association Networking and Educational Event
April 23, 2019
 · 
3 min read
BioCapital
New Insights on an Ancient Disease and Evidence of Effective Therapy
March 21, 2019
 · 
1 min read
Load More
JOBS